发明授权
US07855167B2 In vivo screening of protein-protein interactions with protein-fragment complementation assays
失效
蛋白质 - 蛋白质相互作用与蛋白质片段互补测定的体内筛选
- 专利标题: In vivo screening of protein-protein interactions with protein-fragment complementation assays
- 专利标题(中): 蛋白质 - 蛋白质相互作用与蛋白质片段互补测定的体内筛选
-
申请号: US10728355申请日: 2003-12-05
-
公开(公告)号: US07855167B2公开(公告)日: 2010-12-21
- 发明人: Stephen William Watson Michnick , Ingrid Remy , Jane Lamerdin
- 申请人: Stephen William Watson Michnick , Ingrid Remy , Jane Lamerdin
- 申请人地址: US CA San Ramon
- 专利权人: ODYSSEY THERA, Inc.
- 当前专利权人: ODYSSEY THERA, Inc.
- 当前专利权人地址: US CA San Ramon
- 代理商 Isaac A. Angres
- 主分类号: C40B20/08
- IPC分类号: C40B20/08 ; C40B30/10 ; C12Q1/70 ; C12P21/04 ; C07H21/02 ; C07H21/04
摘要:
The present invention describes rapid methods to screen for biomolecular interactions in vivo based on protein fragment complementation assays (PCA). We have demonstrated an in vivo library-versus-library screening strategy that has numerous applications in the identification of novel protein-protein interactions and in directed evolution. Also we demonstrate the detection of protein-protein interactions starting with defined (full-length) cDNAs, and the concomitant generation of functional assays that provide initial validation of the cDNA products as being biologically relevant. Also, we screened a large cDNA collection using automated PCA, combined with quantitative detection of protein-protein complexes. The invention enables bait-vs.-library, library-vs.-library and defined gene screening in any type of cell or cellular context, and using a wide range of reporters and detection methods. The invention allows for identifying and validating genes involved in any cellular process and also provide assays to study effects of potential drugs, or gene knockouts on specific pathways.
公开/授权文献
信息查询